Lofepramine

Lofepramine
Clinical data
Trade namesGamanil, Lomont, Tymelyt, others
Other namesLopramine; DB-2182; Leo-460; WHR-2908A
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
Pharmacokinetic data
Bioavailability7%
Protein binding99%
MetabolismHepatic (via cytochrome P450, including CYP2D6)
MetabolitesDesipramine (major)
Elimination half-lifeUp to 5 hours; 12–24 hours (active metabolites)
ExcretionUrine, feces (mostly as metabolites)
Identifiers
  • N-(4-chlorobenzoylmethyl)-3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.041.254
Chemical and physical data
FormulaC26H27ClN2O
Molar mass418.97 g·mol−1
3D model (JSmol)
  • Clc1ccc(cc1)C(=O)CN(C)CCCN4c2ccccc2CCc3c4cccc3
  • InChI=1S/C26H27ClN2O/c1-28(19-26(30)22-13-15-23(27)16-14-22)17-6-18-29-24-9-4-2-7-20(24)11-12-21-8-3-5-10-25(21)29/h2-5,7-10,13-16H,6,11-12,17-19H2,1H3 Y
  • Key:SAPNXPWPAUFAJU-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Lofepramine, sold under the brand names Gamanil, Lomont, and Tymelyt among others, is a tricyclic antidepressant (TCA) which is used to treat depression. The TCAs are so named as they share the common property of having three rings in their chemical structure. Like most TCAs lofepramine is believed to work in relieving depression by increasing concentrations of the neurotransmitters norepinephrine and serotonin in the synapse, by inhibiting their reuptake. It is usually considered a third-generation TCA, as unlike the first- and second-generation TCAs it is relatively safe in overdose and has milder and less frequent side effects.

Lofepramine is not available in the United States, Canada, Australia or New Zealand, although it is available in Ireland, Japan, South Africa and the United Kingdom, among other countries.